TP53 and cancer: PIWIL2 promoted cancer cell proliferation via increasing c-Myc expression by facilitating NME2 binding to the G4-motif [21], facilitated cancer cell migration via TBCB [22] and resisted apoptosis by regulating TP53 and TGF-β receptor [23–25].